Prospect: Information for the User
Donepezilo TecniGen 5 mg Film-Coated Tablets
Donepezil Hydrochloride
Read this prospect carefully before starting to take this medicine, as it contains important information for you:
Donepezilo TecniGen (donepezil hydrochloride) belongs to a group of medications called acetylcholinesterase inhibitors. Donepezilo increases the levels of a substance (acetylcholine) in the brain involved in memory function, slowing down the breakdown of acetylcholine.
It is used to treat the symptoms of dementia in individuals diagnosed with mild to moderately severe Alzheimer's disease. Symptoms include increased memory loss, confusion, and changes in behavior. As a result, patients with Alzheimer's disease increasingly have difficulty performing their normal daily activities.
It is a medication for use only in adult patients.
Do not take Donepezilo TecniGen
Warnings and precautions
Consult your doctor or pharmacist before starting to take Donepezilo TecniGen.
Inform your doctor if you have or have had:
Also inform your doctor if you are pregnant or think you may be pregnant.
Interaction of Donepezilo TecniGen with other medications
Inform your doctor or pharmacist if you are taking, have taken recently or may have to take other medications. This includes medications that your doctor has not prescribed but that you may have acquired yourself at the pharmacy. It also applies to medications that you may have to take in the future if you continue to take Donepezilo TecniGen. These medications may weaken or enhance the effects of Donepezilo TecniGen.
In particular, it is essential to inform your doctor or pharmacist if you are taking any of the following types of medications:
If you are to be operated on with general anesthesia, you must inform your doctor and anesthesiologist that you are taking Donepezilo TecniGen, as this medication may affect the amount of anesthetic needed.
Inform your doctor if you have any kidney or liver disease. Patients with severe liver disease should not take Donepezilo TecniGen. Donepezilo TecniGen may be used in patients with mild to moderate liver disease and kidney disease.
Inform your doctor or pharmacist about the name of your caregiver. Your caregiver may help you take the medication prescribed by your doctor.
Donepezilo TecniGen with food, drink and alcohol
Food does not affect the absorption of Donepezilo TecniGen.
Donepezilo TecniGen should not be taken with alcohol, as alcohol may change its effect.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, or think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Donepezilo TecniGen should not be used during breastfeeding.
Donepezilo TecniGen should not be used during pregnancy except in clearly necessary cases.
Consult your doctor or pharmacist before taking any medication.
Driving and operating machinery
Your condition may affect your ability to drive or operate machinery and you should not engage in these activities unless your doctor tells you it is safe to do so. Donepezilo may cause dizziness and drowsiness, mainly at the start of treatment or when increasing the dose. If you experience these effects, you should not drive or operate machinery.
Donepezilo TecniGen contains lactose
If your doctor has told you that you have intolerance to certain sugars, consult with him before taking this medication.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
How much Donepezilo TecniGen should you take?
You will usually start taking 5 mg (1 white tablet) at night. After a month, your doctor may tell you to take 10 mg (1 yellow tablet) at night.
Swallow the tablet with water or another drink before going to bed at night.If you have abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend that you take donepezilo in the morning.The dose may change depending on the duration of treatment or your doctor's recommendation. The maximum recommended dose is 10 mg at night.
Always follow the recommendations of your doctor or pharmacist on how and when to take your medication. Do not change the dose yourself without consulting your doctor.
For how long should you take Donepezilo TecniGen?
Your doctor or pharmacist will tell you how long you should take your tablets. You will need to visit your doctor periodically to review your treatment and analyze your symptoms.
If you interrupt treatment with Donepezilo TecniGen
Do not stop taking the tablets unless your doctor tells you to. When treatment with Donepezilo TecniGen is interrupted, the benefits of your treatment disappear gradually.
If you take more Donepezilo TecniGen than you should
Do not take more than one tablet a day. In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested. Always carry the tablets and packaging with you so that the doctor knows what you are taking.
If you take more Donepezilo TecniGen than you should, you may experience symptoms such as feeling unwell, salivation, sweating, slow heart rate, low blood pressure (dizziness when standing up), breathing difficulties, loss of consciousness, seizures, or convulsions.
If you forgot to take Donepezilo TecniGen
If you forgot to take a dose, take only one dose the next day at the usual time. Do not take a double dose to compensate for missed doses.
If you forgot to take the medication for more than a week, consult your doctor before resuming the medication.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
The following side effects have been reported in people who have taken Donepezilo TecniGen. Inform your doctor if you have any of these side effects while taking Donepezilo TecniGen.
Severe side effects
You must inform your doctor immediately if you observe the mentioned severe side effects. You may need urgent medical treatment.
Very common side effects (may affect more than 1 in 10 people)
Common side effects (may affect up to 1 in 10 people)
Rare side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Unknown frequency
Unknown frequency (cannot be estimated from available data)
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:http://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date shown on the packaging. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and unused medications at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and unused medications. By doing so, you will help protect the environment.
Composition of Donepezilo TecniGen
The active ingredient is donepezilo hydrochloride.
Each tablet contains 5 mg of donepezilo hydrochloride (equivalent to 4.56 mg of donepezilo)
The other components are:Core:Lactose monohydrate, Microcrystalline cellulose, Cornstarch, Hydroxypropyl cellulose, Magnesium stearate.Covering:Hydroxypropyl methylcellulose, Titanium dioxide, Macrogol 400, and Talc.
Appearance of the product and packaging size
Coated tablets, round, convex, and white in color.
Available in blisters in packaging of 28 or 56 coated tablets.
Only some packaging sizes may be commercially available.
Other presentations:
Donepezilo TecniGen 10 mg coated tablets. Packaging of 28 tablets.
Marketing Authorization Holder and Responsible for Manufacturing:
Marketing Authorization Holder:
Tecnimede España Industria Farmacéutica, S.A.
Avda. de Bruselas, 13, 3rd Floor.
28108 Alcobendas (Madrid) SPAIN
Responsible for Manufacturing:
Atlantic Pharma – Produções Farmacêuticas SA
Rua da Tapada Grande, 2, Abrunheira, 2710 – 089 Sintra
Portugal
Last review date of this leaflet: March 2023
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.